Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-07-27

EMA Authorised: Apixaban Accord (apixaban) — Accord Healthcare S.L.U.

View source ↗

Summary

Authorised status for Apixaban Accord (apixaban) by Accord Healthcare S.L.U. for venous thromboembolism, stroke, and arthroplasty indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban Accord (apixaban)

Snippet

Status: Authorised. Therapeutic area: Venous Thromboembolism;Stroke;Arthroplasty. MAH: Accord Healthcare S.L.U.. Decision date: 24/07/2026